✦ LIBER ✦

A Phase II Study of Plerixafor (AMD3100) plus G-CSF for Autologous Hematopoietic Progenitor Cell Mobilization in Patients with Hodgkin Lymphoma

✍ Scribed by Amanda Cashen; Sandra Lopez; Feng Gao; Gary Calandra; Ron MacFarland; Karin Badel; John DiPersio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AMD3100 plus G-CSF rapidly mobilizes hem

✍ P. Stiff; I. Micallef; P. McCarthy; M. Magalhaes-Silverman; N. Fromenberg; D. We 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 52 KB

99: Single-center experience with the ea

✍ C.H. Roberts; H.M. Chung; K.S. Candler; G. Calandra; K. Badel; J.M. McCarty 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Phase I/II Study of Intravenous Plerixaf

✍ A. Cashen; M. Rettig; F. Gao; T. Reineck; C. Abboud; K. Stockerl-Goldstein; R. V 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

The Cost-Effectiveness of Plerixafor Plu

✍ S.M. Kymes; M. Gregory; D.L. Lambert; K.R. Carson; I. Pusic; J.F. DiPersio 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Phase II Trial of Intravenously Administ

✍ S. Kumar; J. Mikhael; M. Lacy; B. LaPlant; F. Buadi; D. Dingli; M. Gertz; T. Mic 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Health Economic Outcome Analysis Of Stem

✍ I. Pusic; S.M. Kymes; D.L. Lambert; M. Gregory; J.F. DiPersio 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB